US modafinil charge devastates Sun profit

Sun’s managing director, Dilip Shanghvi, has defended the “underlying health” of the company after a sizeable charge linked to antitrust litigation almost completely wiped out Sun’s pre-tax profit in its financial second quarter, while a sales decline in India limited overall turnover growth.